Summary
According to APO Research, The global Computational Toxicology Solutions market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Computational Toxicology Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Computational Toxicology Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Computational Toxicology Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Computational Toxicology Solutions is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Computational Toxicology Solutions include Instem (Leadscope), Lhasa Limited, MultiCASE, Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene and Deciphex (Patholytix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Computational Toxicology Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Computational Toxicology Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Computational Toxicology Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Computational Toxicology Solutions revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Computational Toxicology Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Computational Toxicology Solutions revenue, projected growth trends, production technology, application and end-user industry.
Computational Toxicology Solutions segment by Company
Instem (Leadscope)
Lhasa Limited
MultiCASE
Inotiv
Simulations Plus Inc
Schrodinger
Aclaris
Evogene
Deciphex (Patholytix)
Exscientia
Computational Toxicology Solutions segment by Type
On-Premise
Cloud-Based
Computational Toxicology Solutions segment by Application
Academia
Enterprise
Computational Toxicology Solutions segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Toxicology Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Computational Toxicology Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Toxicology Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Computational Toxicology Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Computational Toxicology Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computational Toxicology Solutions revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Computational Toxicology Solutions Market by Type
1.2.1 Global Computational Toxicology Solutions Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 On-Premise
1.2.3 Cloud-Based
1.3 Computational Toxicology Solutions Market by Application
1.3.1 Global Computational Toxicology Solutions Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Academia
1.3.3 Enterprise
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Computational Toxicology Solutions Market Dynamics
2.1 Computational Toxicology Solutions Industry Trends
2.2 Computational Toxicology Solutions Industry Drivers
2.3 Computational Toxicology Solutions Industry Opportunities and Challenges
2.4 Computational Toxicology Solutions Industry Restraints
3 Global Growth Perspective
3.1 Global Computational Toxicology Solutions Market Perspective (2019-2030)
3.2 Global Computational Toxicology Solutions Growth Trends by Region
3.2.1 Global Computational Toxicology Solutions Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Computational Toxicology Solutions Market Size by Region (2019-2024)
3.2.3 Global Computational Toxicology Solutions Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Computational Toxicology Solutions Revenue by Players
4.1.1 Global Computational Toxicology Solutions Revenue by Players (2019-2024)
4.1.2 Global Computational Toxicology Solutions Revenue Market Share by Players (2019-2024)
4.1.3 Global Computational Toxicology Solutions Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Computational Toxicology Solutions Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Computational Toxicology Solutions Key Players Headquarters & Area Served
4.4 Global Computational Toxicology Solutions Players, Product Type & Application
4.5 Global Computational Toxicology Solutions Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Computational Toxicology Solutions Market CR5 and HHI
4.6.2 Global Top 5 and 10 Computational Toxicology Solutions Players Market Share by Revenue in 2023
4.6.3 2023 Computational Toxicology Solutions Tier 1, Tier 2, and Tier 3
5 Computational Toxicology Solutions Market Size by Type
5.1 Global Computational Toxicology Solutions Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Computational Toxicology Solutions Revenue by Type (2019-2030)
5.3 Global Computational Toxicology Solutions Revenue Market Share by Type (2019-2030)
6 Computational Toxicology Solutions Market Size by Application
6.1 Global Computational Toxicology Solutions Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Computational Toxicology Solutions Revenue by Application (2019-2030)
6.3 Global Computational Toxicology Solutions Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Instem (Leadscope)
7.1.1 Instem (Leadscope) Comapny Information
7.1.2 Instem (Leadscope) Business Overview
7.1.3 Instem (Leadscope) Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.1.4 Instem (Leadscope) Computational Toxicology Solutions Product Portfolio
7.1.5 Instem (Leadscope) Recent Developments
7.2 Lhasa Limited
7.2.1 Lhasa Limited Comapny Information
7.2.2 Lhasa Limited Business Overview
7.2.3 Lhasa Limited Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.2.4 Lhasa Limited Computational Toxicology Solutions Product Portfolio
7.2.5 Lhasa Limited Recent Developments
7.3 MultiCASE
7.3.1 MultiCASE Comapny Information
7.3.2 MultiCASE Business Overview
7.3.3 MultiCASE Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.3.4 MultiCASE Computational Toxicology Solutions Product Portfolio
7.3.5 MultiCASE Recent Developments
7.4 Inotiv
7.4.1 Inotiv Comapny Information
7.4.2 Inotiv Business Overview
7.4.3 Inotiv Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.4.4 Inotiv Computational Toxicology Solutions Product Portfolio
7.4.5 Inotiv Recent Developments
7.5 Simulations Plus Inc
7.5.1 Simulations Plus Inc Comapny Information
7.5.2 Simulations Plus Inc Business Overview
7.5.3 Simulations Plus Inc Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.5.4 Simulations Plus Inc Computational Toxicology Solutions Product Portfolio
7.5.5 Simulations Plus Inc Recent Developments
7.6 Schrodinger
7.6.1 Schrodinger Comapny Information
7.6.2 Schrodinger Business Overview
7.6.3 Schrodinger Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.6.4 Schrodinger Computational Toxicology Solutions Product Portfolio
7.6.5 Schrodinger Recent Developments
7.7 Aclaris
7.7.1 Aclaris Comapny Information
7.7.2 Aclaris Business Overview
7.7.3 Aclaris Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.7.4 Aclaris Computational Toxicology Solutions Product Portfolio
7.7.5 Aclaris Recent Developments
7.8 Evogene
7.8.1 Evogene Comapny Information
7.8.2 Evogene Business Overview
7.8.3 Evogene Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.8.4 Evogene Computational Toxicology Solutions Product Portfolio
7.8.5 Evogene Recent Developments
7.9 Deciphex (Patholytix)
7.9.1 Deciphex (Patholytix) Comapny Information
7.9.2 Deciphex (Patholytix) Business Overview
7.9.3 Deciphex (Patholytix) Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.9.4 Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio
7.9.5 Deciphex (Patholytix) Recent Developments
7.10 Exscientia
7.10.1 Exscientia Comapny Information
7.10.2 Exscientia Business Overview
7.10.3 Exscientia Computational Toxicology Solutions Revenue and Gross Margin (2019-2024)
7.10.4 Exscientia Computational Toxicology Solutions Product Portfolio
7.10.5 Exscientia Recent Developments
8 North America
8.1 North America Computational Toxicology Solutions Revenue (2019-2030)
8.2 North America Computational Toxicology Solutions Revenue by Type (2019-2030)
8.2.1 North America Computational Toxicology Solutions Revenue by Type (2019-2024)
8.2.2 North America Computational Toxicology Solutions Revenue by Type (2025-2030)
8.3 North America Computational Toxicology Solutions Revenue Share by Type (2019-2030)
8.4 North America Computational Toxicology Solutions Revenue by Application (2019-2030)
8.4.1 North America Computational Toxicology Solutions Revenue by Application (2019-2024)
8.4.2 North America Computational Toxicology Solutions Revenue by Application (2025-2030)
8.5 North America Computational Toxicology Solutions Revenue Share by Application (2019-2030)
8.6 North America Computational Toxicology Solutions Revenue by Country
8.6.1 North America Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Computational Toxicology Solutions Revenue by Country (2019-2024)
8.6.3 North America Computational Toxicology Solutions Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Computational Toxicology Solutions Revenue (2019-2030)
9.2 Europe Computational Toxicology Solutions Revenue by Type (2019-2030)
9.2.1 Europe Computational Toxicology Solutions Revenue by Type (2019-2024)
9.2.2 Europe Computational Toxicology Solutions Revenue by Type (2025-2030)
9.3 Europe Computational Toxicology Solutions Revenue Share by Type (2019-2030)
9.4 Europe Computational Toxicology Solutions Revenue by Application (2019-2030)
9.4.1 Europe Computational Toxicology Solutions Revenue by Application (2019-2024)
9.4.2 Europe Computational Toxicology Solutions Revenue by Application (2025-2030)
9.5 Europe Computational Toxicology Solutions Revenue Share by Application (2019-2030)
9.6 Europe Computational Toxicology Solutions Revenue by Country
9.6.1 Europe Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Computational Toxicology Solutions Revenue by Country (2019-2024)
9.6.3 Europe Computational Toxicology Solutions Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Computational Toxicology Solutions Revenue (2019-2030)
10.2 China Computational Toxicology Solutions Revenue by Type (2019-2030)
10.2.1 China Computational Toxicology Solutions Revenue by Type (2019-2024)
10.2.2 China Computational Toxicology Solutions Revenue by Type (2025-2030)
10.3 China Computational Toxicology Solutions Revenue Share by Type (2019-2030)
10.4 China Computational Toxicology Solutions Revenue by Application (2019-2030)
10.4.1 China Computational Toxicology Solutions Revenue by Application (2019-2024)
10.4.2 China Computational Toxicology Solutions Revenue by Application (2025-2030)
10.5 China Computational Toxicology Solutions Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Computational Toxicology Solutions Revenue (2019-2030)
11.2 Asia Computational Toxicology Solutions Revenue by Type (2019-2030)
11.2.1 Asia Computational Toxicology Solutions Revenue by Type (2019-2024)
11.2.2 Asia Computational Toxicology Solutions Revenue by Type (2025-2030)
11.3 Asia Computational Toxicology Solutions Revenue Share by Type (2019-2030)
11.4 Asia Computational Toxicology Solutions Revenue by Application (2019-2030)
11.4.1 Asia Computational Toxicology Solutions Revenue by Application (2019-2024)
11.4.2 Asia Computational Toxicology Solutions Revenue by Application (2025-2030)
11.5 Asia Computational Toxicology Solutions Revenue Share by Application (2019-2030)
11.6 Asia Computational Toxicology Solutions Revenue by Country
11.6.1 Asia Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Computational Toxicology Solutions Revenue by Country (2019-2024)
11.6.3 Asia Computational Toxicology Solutions Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Computational Toxicology Solutions Revenue (2019-2030)
12.2 MEALA Computational Toxicology Solutions Revenue by Type (2019-2030)
12.2.1 MEALA Computational Toxicology Solutions Revenue by Type (2019-2024)
12.2.2 MEALA Computational Toxicology Solutions Revenue by Type (2025-2030)
12.3 MEALA Computational Toxicology Solutions Revenue Share by Type (2019-2030)
12.4 MEALA Computational Toxicology Solutions Revenue by Application (2019-2030)
12.4.1 MEALA Computational Toxicology Solutions Revenue by Application (2019-2024)
12.4.2 MEALA Computational Toxicology Solutions Revenue by Application (2025-2030)
12.5 MEALA Computational Toxicology Solutions Revenue Share by Application (2019-2030)
12.6 MEALA Computational Toxicology Solutions Revenue by Country
12.6.1 MEALA Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Computational Toxicology Solutions Revenue by Country (2019-2024)
12.6.3 MEALA Computational Toxicology Solutions Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Computational Toxicology Solutions Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. On-Premise Major Manufacturers
Table 2. Cloud-Based Major Manufacturers
Table 3. Global Computational Toxicology Solutions Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Academia Major Manufacturers
Table 5. Enterprise Major Manufacturers
Table 6. Computational Toxicology Solutions Industry Trends
Table 7. Computational Toxicology Solutions Industry Drivers
Table 8. Computational Toxicology Solutions Industry Opportunities and Challenges
Table 9. Computational Toxicology Solutions Industry Restraints
Table 10. Global Computational Toxicology Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Computational Toxicology Solutions Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Computational Toxicology Solutions Market Share by Region (2019-2024)
Table 13. Global Computational Toxicology Solutions Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Computational Toxicology Solutions Market Share by Region (2025-2030)
Table 15. Global Computational Toxicology Solutions Revenue by Players (US$ Million) & (2019-2024)
Table 16. Global Computational Toxicology Solutions Revenue Market Share by Players (2019-2024)
Table 17. Global Computational Toxicology Solutions Key Players Ranking, 2022 VS 2023 VS 2024
Table 18. Global Computational Toxicology Solutions Key Players Headquarters & Area Served
Table 19. Global Computational Toxicology Solutions Players, Product Type & Application
Table 20. Global Computational Toxicology Solutions Players Commercialization Time
Table 21. Global Players Market Concentration Ratio (CR5 and HHI)
Table 22. Global Computational Toxicology Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 23. Global Computational Toxicology Solutions Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 25. Global Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Table 26. Global Computational Toxicology Solutions Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 27. Global Computational Toxicology Solutions Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 28. Global Computational Toxicology Solutions Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 30. Global Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Table 31. Global Computational Toxicology Solutions Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 32. Global Computational Toxicology Solutions Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 33. Instem (Leadscope) Company Information
Table 34. Instem (Leadscope) Business Overview
Table 35. Instem (Leadscope) Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 36. Instem (Leadscope) Computational Toxicology Solutions Product Portfolio
Table 37. Instem (Leadscope) Recent Development
Table 38. Lhasa Limited Company Information
Table 39. Lhasa Limited Business Overview
Table 40. Lhasa Limited Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 41. Lhasa Limited Computational Toxicology Solutions Product Portfolio
Table 42. Lhasa Limited Recent Development
Table 43. MultiCASE Company Information
Table 44. MultiCASE Business Overview
Table 45. MultiCASE Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 46. MultiCASE Computational Toxicology Solutions Product Portfolio
Table 47. MultiCASE Recent Development
Table 48. Inotiv Company Information
Table 49. Inotiv Business Overview
Table 50. Inotiv Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 51. Inotiv Computational Toxicology Solutions Product Portfolio
Table 52. Inotiv Recent Development
Table 53. Simulations Plus Inc Company Information
Table 54. Simulations Plus Inc Business Overview
Table 55. Simulations Plus Inc Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 56. Simulations Plus Inc Computational Toxicology Solutions Product Portfolio
Table 57. Simulations Plus Inc Recent Development
Table 58. Schrodinger Company Information
Table 59. Schrodinger Business Overview
Table 60. Schrodinger Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 61. Schrodinger Computational Toxicology Solutions Product Portfolio
Table 62. Schrodinger Recent Development
Table 63. Aclaris Company Information
Table 64. Aclaris Business Overview
Table 65. Aclaris Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 66. Aclaris Computational Toxicology Solutions Product Portfolio
Table 67. Aclaris Recent Development
Table 68. Evogene Company Information
Table 69. Evogene Business Overview
Table 70. Evogene Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 71. Evogene Computational Toxicology Solutions Product Portfolio
Table 72. Evogene Recent Development
Table 73. Deciphex (Patholytix) Company Information
Table 74. Deciphex (Patholytix) Business Overview
Table 75. Deciphex (Patholytix) Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 76. Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio
Table 77. Deciphex (Patholytix) Recent Development
Table 78. Exscientia Company Information
Table 79. Exscientia Business Overview
Table 80. Exscientia Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 81. Exscientia Computational Toxicology Solutions Product Portfolio
Table 82. Exscientia Recent Development
Table 83. North America Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 84. North America Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 85. North America Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 86. North America Computational Toxicology Solutions Revenue by Country (2019-2024) & (US$ Million)
Table 87. North America Computational Toxicology Solutions Revenue by Country (2025-2030) & (US$ Million)
Table 88. Europe Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 89. Europe Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 90. Europe Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 91. Europe Computational Toxicology Solutions Revenue by Country (2019-2024) & (US$ Million)
Table 92. Europe Computational Toxicology Solutions Revenue by Country (2025-2030) & (US$ Million)
Table 93. China Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 94. China Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 95. Asia Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 96. Asia Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 97. Asia Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 98. Asia Computational Toxicology Solutions Revenue by Country (2019-2024) & (US$ Million)
Table 99. Asia Computational Toxicology Solutions Revenue by Country (2025-2030) & (US$ Million)
Table 100. MEALA Computational Toxicology Solutions Revenue by Type (2019-2024) & (US$ Million)
Table 101. MEALA Computational Toxicology Solutions Revenue by Application (2019-2024) & (US$ Million)
Table 102. MEALA Computational Toxicology Solutions Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. MEALA Computational Toxicology Solutions Revenue by Country (2019-2024) & (US$ Million)
Table 104. MEALA Computational Toxicology Solutions Revenue by Country (2025-2030) & (US$ Million)
Table 105. Research Programs/Design for This Report
Table 106. Authors List of This Report
Table 107. Secondary Sources
Table 108. Primary Sources
List of Figures
Figure 1. Computational Toxicology Solutions Product Picture
Figure 2. Global Computational Toxicology Solutions Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Computational Toxicology Solutions Market Size Share 2019 VS 2023 VS 2030
Figure 4. On-Premise Picture
Figure 5. Cloud-Based Picture
Figure 6. Global Computational Toxicology Solutions Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Computational Toxicology Solutions Market Size Share 2019 VS 2023 VS 2030
Figure 8. Academia Picture
Figure 9. Enterprise Picture
Figure 10. Global Computational Toxicology Solutions Market Size (US$ Million) & (2019-2030)
Figure 11. Global Computational Toxicology Solutions Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Computational Toxicology Solutions Market Share by Region: 2019 VS 2023 VS 2030
Figure 13. Global Computational Toxicology Solutions Players Revenue Share Top 10 and Top 5 in 2023
Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 15. Global Computational Toxicology Solutions Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Computational Toxicology Solutions Revenue Market Share 2019 VS 2023 VS 2030
Figure 17. Global Computational Toxicology Solutions Revenue Market Share by Type (2019-2030)
Figure 18. Global Computational Toxicology Solutions Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Computational Toxicology Solutions Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 20. Global Computational Toxicology Solutions Revenue Market Share by Application (2019-2030)
Figure 21. North America Computational Toxicology Solutions Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Figure 23. North America Computational Toxicology Solutions Revenue Share by Type (2019-2030)
Figure 24. North America Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Figure 25. North America Computational Toxicology Solutions Revenue Share by Application (2019-2030)
Figure 26. North America Computational Toxicology Solutions Revenue Share by Country (2019-2030)
Figure 27. United States Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 28. Canada Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Europe Computational Toxicology Solutions Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Figure 31. Europe Computational Toxicology Solutions Revenue Share by Type (2019-2030)
Figure 32. Europe Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Figure 33. Europe Computational Toxicology Solutions Revenue Share by Application (2019-2030)
Figure 34. Europe Computational Toxicology Solutions Revenue Share by Country (2019-2030)
Figure 35. Germany Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 36. France Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. U.K. Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Italy Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Russia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Nordic Countries Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. China Computational Toxicology Solutions Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Figure 43. China Computational Toxicology Solutions Revenue Share by Type (2019-2030)
Figure 44. China Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Figure 45. China Computational Toxicology Solutions Revenue Share by Application (2019-2030)
Figure 46. Asia Computational Toxicology Solutions Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 47. Asia Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Figure 48. Asia Computational Toxicology Solutions Revenue Share by Type (2019-2030)
Figure 49. Asia Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Figure 50. Asia Computational Toxicology Solutions Revenue Share by Application (2019-2030)
Figure 51. Asia Computational Toxicology Solutions Revenue Share by Country (2019-2030)
Figure 52. Japan Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 53. South Korea Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. India Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. Australia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. China Taiwan Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Southeast Asia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. MEALA Computational Toxicology Solutions Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 59. MEALA Computational Toxicology Solutions Revenue by Type (2025-2030) & (US$ Million)
Figure 60. MEALA Computational Toxicology Solutions Revenue Share by Type (2019-2030)
Figure 61. MEALA Computational Toxicology Solutions Revenue by Application (2025-2030) & (US$ Million)
Figure 62. MEALA Computational Toxicology Solutions Revenue Share by Application (2019-2030)
Figure 63. MEALA Computational Toxicology Solutions Revenue Share by Country (2019-2030)
Figure 64. Mexico Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. South Korea Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Brazil Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Israel Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Argentina Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Colombia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Turkey Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Saudi Arabia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. UAE Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Years Considered
Figure 74. Research Process
Figure 75. Key Executives Interviewed
